CAS RN: 264273-08-7
(S)-FMOC-4-AMINO-2-CARBOXYMETHYL-1,3,4,5-TETRAHYDRO-2H-[2]-BENZAZEPIN-3-ONE
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g, 0.25g, 1g
Available purity: >95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 264273-08-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
>95%
0
Out of Stock
Beijing
Inquiry
0.25g
>95%
0
Out of Stock
Hong Kong
Inquiry
1g
>95%
0
Out of Stock
Shenzhen
Inquiry
264273-08-7 / 2-[(4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-3-oxo-4,5-dihydro-1H-2-benzazepin-2-yl]acetic acid
Standard CAS: 264273-08-7
Multi CAS: Yes
Basic Information
copy
CAS
264273-08-7 copy
Multi CAS
Yes copy
Molecular Formula
C27H24N2O5 copy
Molecular Weight
456.500000 copy
Exact Mass
456.168522 copy
InChI
InChI=1S/C27H24N2O5/c30-25(31)15-29-14-18-8-2-1-7-17(18)13-24(26(29)32)28-27(33)34-16-23-21-11-5-3-9-19(21)20-10-4-6-12-22(20)23/h1-12,23-24H,13-16H2,(H,28,33)(H,30,31)/t24-/m0/s1 copy
InChIKey
RPAHAHMAXJASPS-DEOSSOPVSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
34 copy
Aromatic heavy atom count
18 copy
Fraction Csp3
0.22 copy
Rotatable bonds
5 copy
H-bond acceptors
4 copy
H-bond donors
2 copy
Molar refractivity
125.19 copy
TPSA
95.94 copy
LogP / Solubility
WLOGP
3.56 copy
MLOGP
3.17 copy
XLogP3
3.7 copy
Consensus LogP
3.48 copy
Log S (ESOL)
-4.98 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-5.88 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-6.18 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-2.97 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
4 copy